124 related articles for article (PubMed ID: 16307448)
1. Involvement of alpha1beta1 integrin in insulin-like growth factor-1-mediated protection of PC12 neuronal processes from tumor necrosis factor-alpha-induced injury.
Wang JY; Grabacka M; Marcinkiewicz C; Staniszewska I; Peruzzi F; Khalili K; Amini S; Reiss K
J Neurosci Res; 2006 Jan; 83(1):7-18. PubMed ID: 16307448
[TBL] [Abstract][Full Text] [Related]
2. IGF-1 protects oligodendrocyte progenitors against TNFalpha-induced damage by activation of PI3K/Akt and interruption of the mitochondrial apoptotic pathway.
Pang Y; Zheng B; Fan LW; Rhodes PG; Cai Z
Glia; 2007 Aug; 55(11):1099-107. PubMed ID: 17577243
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by alphavbeta3 integrin signaling.
Shen MR; Hsu YM; Hsu KF; Chen YF; Tang MJ; Chou CY
Carcinogenesis; 2006 May; 27(5):962-71. PubMed ID: 16400188
[TBL] [Abstract][Full Text] [Related]
4. Interaction between serine phosphorylated IRS-1 and beta1-integrin affects the stability of neuronal processes.
Wang JY; Gualco E; Peruzzi F; Sawaya BE; Passiatore G; Marcinkiewicz C; Staniszewska I; Ferrante P; Amini S; Khalili K; Reiss K
J Neurosci Res; 2007 Aug; 85(11):2360-73. PubMed ID: 17593555
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of SCLC growth by the A12 anti-IGF-1R monoclonal antibody correlates with inhibition of Akt.
Yeh J; Litz J; Hauck P; Ludwig DL; Krystal GW
Lung Cancer; 2008 May; 60(2):166-74. PubMed ID: 18006183
[TBL] [Abstract][Full Text] [Related]
6. Activation of the insulin-like growth factor-I receptor inhibits tumor necrosis factor-induced cell death.
Wu Y; Tewari M; Cui S; Rubin R
J Cell Physiol; 1996 Sep; 168(3):499-509. PubMed ID: 8816904
[TBL] [Abstract][Full Text] [Related]
7. Neuronal protection from glucose deprivation via modulation of glucose transport and inhibition of apoptosis: a role for the insulin-like growth factor system.
Russo VC; Kobayashi K; Najdovska S; Baker NL; Werther GA
Brain Res; 2004 May; 1009(1-2):40-53. PubMed ID: 15120582
[TBL] [Abstract][Full Text] [Related]
8. Comparison of three approaches for inhibiting insulin-like growth factor I receptor and their effects on NSCLC cell lines in vitro.
Cosaceanu D; Carapancea M; Alexandru O; Budiu R; Martinsson HS; Starborg M; Vrabete M; Kanter L; Lewensohn R; Dricu A
Growth Factors; 2007 Feb; 25(1):1-8. PubMed ID: 17454144
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma.
Friedrichs N; Küchler J; Endl E; Koch A; Czerwitzki J; Wurst P; Metzger D; Schulte JH; Holst MI; Heukamp LC; Larsson O; Tanaka S; Kawai A; Wardelmann E; Buettner R; Pietsch T; Hartmann W
J Pathol; 2008 Dec; 216(4):428-39. PubMed ID: 18855347
[TBL] [Abstract][Full Text] [Related]
10. The small Gtpase ras is involved in growth factor-regulated expression of the alpha1 integrin subunit in PC12 cells.
Danker K; Mechai N; Lucka L; Reutter W; Horstkorte R
Biol Chem; 2001 Jun; 382(6):969-72. PubMed ID: 11501763
[TBL] [Abstract][Full Text] [Related]
11. The WT1 Wilms' tumor suppressor gene is a downstream target for insulin-like growth factor-I (IGF-I) action in PC12 cells.
Sarfstein R; Werner H
J Neurochem; 2006 Nov; 99(3):818-26. PubMed ID: 16911581
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of breast cancer cell lines to the novel insulin-like growth factor-1 receptor (IGF-1R) inhibitor NVP-AEW541 is dependent on the level of IRS-1 expression.
Mukohara T; Shimada H; Ogasawara N; Wanikawa R; Shimomura M; Nakatsura T; Ishii G; Park JO; Jänne PA; Saijo N; Minami H
Cancer Lett; 2009 Sep; 282(1):14-24. PubMed ID: 19345478
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-1-dependent maintenance of neuronal metabolism through the phosphatidylinositol 3-kinase-Akt pathway is inhibited by C2-ceramide in CAD cells.
Arboleda G; Huang TJ; Waters C; Verkhratsky A; Fernyhough P; Gibson RM
Eur J Neurosci; 2007 May; 25(10):3030-8. PubMed ID: 17561816
[TBL] [Abstract][Full Text] [Related]
14. TNFalpha-induced apoptosis and integrin switching in human extravillous trophoblast cell line.
Fukushima K; Miyamoto S; Komatsu H; Tsukimori K; Kobayashi H; Seki H; Takeda S; Nakano H
Biol Reprod; 2003 May; 68(5):1771-8. PubMed ID: 12606473
[TBL] [Abstract][Full Text] [Related]
15. Dual tyrosine kinase inhibitor for focal adhesion kinase and insulin-like growth factor-I receptor exhibits anticancer effect in esophageal adenocarcinoma in vitro and in vivo.
Watanabe N; Takaoka M; Sakurama K; Tomono Y; Hatakeyama S; Ohmori O; Motoki T; Shirakawa Y; Yamatsuji T; Haisa M; Matsuoka J; Beer DG; Nagatsuka H; Tanaka N; Naomoto Y
Clin Cancer Res; 2008 Jul; 14(14):4631-9. PubMed ID: 18628478
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-I activation of Akt survival cascade in neuronal cells requires the presence of its cognate receptor in caveolae.
Lu X; Kambe F; Cao X; Yamauchi M; Seo H
Exp Cell Res; 2008 Jan; 314(2):342-51. PubMed ID: 18022157
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of regucalcin suppresses cell death and apoptosis in cloned rat hepatoma H4-II-E cells induced by insulin or insulin-like growth factor-I.
Fukaya Y; Yamaguchi M
J Cell Biochem; 2005 Sep; 96(1):145-54. PubMed ID: 15880694
[TBL] [Abstract][Full Text] [Related]
18. Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells.
Fang J; Zhou Q; Shi XL; Jiang BH
Carcinogenesis; 2007 Mar; 28(3):713-23. PubMed ID: 17065200
[TBL] [Abstract][Full Text] [Related]
19. Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I).
Jernberg-Wiklund H; Nilsson K
Adv Cancer Res; 2007; 97():139-65. PubMed ID: 17419944
[TBL] [Abstract][Full Text] [Related]
20. IRS-2 branch of IGF-1 receptor signaling is essential for appropriate timing of myelination.
Freude S; Leeser U; Müller M; Hettich MM; Udelhoven M; Schilbach K; Tobe K; Kadowaki T; Köhler C; Schröder H; Krone W; Brüning JC; Schubert M
J Neurochem; 2008 Nov; 107(4):907-17. PubMed ID: 18717815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
